EWTX | Edgewise Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	31.27 - 33.97
52 Week Range	6.07 - 38.12
Beta	0.44
Implied Volatility	122.49%
IV Rank	32.76%
Day's Volume	870,156
Average Volume	1,115,560
Shares Outstanding	94,688,500
Market Cap	2,986,475,290
Sector	Healthcare
Industry	Biotechnology
IPO Date	2021-03-26

Valuation
Profitability
Growth
Health
P/E Ratio	-21.03
Forward P/E Ratio	N/A
EPS	-1.50
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	97
Country	USA
Website	EWTX

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.

EWTX's peers: ACET, AGEN, ALXO, ATAI, AVTX, BCLI, BMEA, CCCC, CDMO, CELC, CGEM, CLDX, CLSD, CNTA, CORT, CYCC, CYTK, DBVT, DYAI, DYN, ENTA, EQ, ERAS, IPSC, MLYS, TALS, VOR, IKNA, DSGN, XLO, ELYM, HOWL, DBTX, TCRR, RVMD, BDTX, BCEL, PASG, FBRX, FDMT, FENC, FHTX, FOLD, GBIO, GLTO, GMAB, GNFT, HALO, HRMY, IFRX, IMTX, IMUX, CYBN, INSM, IVA, JANX, JSPR, KALV, KRON, KROS, KYMR, LBPH, LGVN, LVTX, LYEL, MDXG, MGNX, MGTX, MNMD, MOLN, MRKR, MRNS, MRVI, NVCT, ORIC, PGEN, PMVP, PRAX, PRTG, RDUS, RLAY, RLMD, RLYB, SLDB, SNDX, SVRA, SYBX, THTX, TNGX, TRDA, TYRA, URGN, VALN, VERA, VIGL, VRCA, VTVT, XBIT, XENE, XNCR, XOMA, YMAB, HLVX, PEPG, QNCX, THRD, IVVD, PROK, OABI, GRI

*Chart delayed

Analyzing fundamentals for EWTX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is strong. For more detailed analysis please see EWTX Fundamentals page.

Watching at EWTX technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, but short-term trend is bearish. More technicals details can be found on EWTX Technicals page.